Company / Income Tax
United Therapeutics Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$379.2M
FY2025
5-year range
$118.1M / $379.2M
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#11 of 204
Health Care
What the data says
Among 204 Health Care companies, United Therapeutics is in the bottom 5% for income tax. Income Tax has increased for 4 consecutive years, from $118M in FY2021 to $379M in FY2025.
Based on SEC 10-K filings.
$379M in FY2025 with a 5-year CAGR of +25.0%. Top quartile in the Health Care sector.
Increased from $290M to $379M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +19.3%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 204This company $379.2M Sector average $118.7M
▼
+219.4% above sector average
Key checks
Key Insights
- United Therapeutics's income tax has grown for 4 consecutive years.
- 5-year CAGR of +25.0%, indicating consistent growth.
- In FY2025, income tax increased 10.3% year-over-year.
- Ranks #11 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $379.2M | +10.3% |
| FY2024 | $343.9M | +18.8% |
| FY2023 | $289.5M | +29.6% |
| FY2022 | $223.3M | +89.1% |
| FY2021 | $118.1M | -4.8% |
| FY2020 | $124.1M | +305.1% |
| FY2019 | -$60.5M | -135.7% |
| FY2018 | $169.7M | -56.8% |
| FY2017 | $392.8M | +13.4% |
| FY2016 | $346.5M | -11.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026